Thought Leader Select Meets Client Needs for More KOLs, Non-Traditional KOLs, Centers of Excellence

April 17, 2014 · Leave a comment

By Brian Castle

A client working to develop new treatments for interstitial lung diseases (ILD) recently approached Thought Leader Select with a new challenge.  An innovative firm, the company realized that it was risking complacency in its thinking, assuming that it knew the right key opinion leaders and centers of excellence in pulmonology to assist in drug development.

Thought Leader Select delivered a comprehensive, cost-effective approach to ensure the company has a more updated understanding of the ILD market.  In addition to helping the company better understand its current roster of KOLs and centers of excellence, Thought Leader Select demonstrated the need to focus efforts at identifying and learning more about other health care professionals who diagnose and treat ILD.

Many product teams have the benefit of sound internal knowledge of globally and nationally-recognized specialist physicians performing breakthrough work in their treatment area.  More problematic for these teams are finding and understanding the work of other health care professionals who play pivotal roles in diagnosis and patient adherence, such as primary care physicians and registered nurses.  For this particular project, Thought Leader Select recognized an unmet need to understand key players in the diagnosis of interstitial lung diseases, pulmonary radiologists and community-based specialists at regional medical centers.

This client engagement is illustrative of several elements that help Thought Leader Select to differentiate its services ... read more »

TAGS:                               

Industry and Academia Square Off on Health Care in North America at the Next CBA-NC Event

April 9, 2014 · Leave a comment

Thought Leader Select founder and President Paul Meade will join Dr. John Paul from the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health to discuss the topic, “Health Care in North America,” at the next Canadian Business Association of North Carolina networking event.

The event will take place on Tuesday, April 22, from 5:30-8:30 pm at the Ingram Collection, a private collection of rare Porsche automobiles in Durham.  Paul Meade and John Paul, will discuss some of the major differences between the U. S. and Canadian health care systems, perhaps even debunking a few misconceptions about each.

Dr. John Paul holds the Associate Chair for Academics, Health Policy, and Management at the Gillings School and teaches and advises undergraduate, masters, and doctoral students in the schools programs in health policy and management.  Prior to his tenure at UNC, Dr. Paul headed business development at RTI International, a global research firm headquartered in the Research Triangle Park, and served as senior director of global health outcomes at pharmaceutical giant GlaxoSmithKline.  He maintains a commitment to working on global health projects and recently served as editor-in-chief of the journal World Health & Population for an eight-year term ending in 2013.

Paul ... read more »

Global Biopharma Re-engages Thought Leader Select to Support Canadian KOL, Centers of Excellence Initiatives in Head and Neck Cancer

March 27, 2014 · Leave a comment

March 27, 2014 (CHAPEL HILL, NC) Thought Leader Select, a firm dedicated to supporting life sciences companies in their collaborative work with the medical community, has begun a strategic engagement in the area of head and neck cancer for the Canadian division of a top global biopharmaceutical company.

The client company chose North Carolina’s Thought Leader Select to assist them with upcoming and ongoing initiatives with oncology key opinion leaders based in Canada’s Centers of Excellence in head and neck cancer.   Headquartered in the Research Triangle region of North Carolina with consultants in the United States and Canada, Thought Leader Select provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies. These custom-tailored services support the necessary and critical industry outreach to and collaboration with leading medical experts, the health care professionals that advance treatment options and promote better public health at regional, national, and global levels.

For the new strategic engagement in head and neck cancer, Thought Leader Select’s in-house research team will assess the skills and dozens of national key opinion leaders across Canada’s provincial health care systems, as well as detail the research and treatment activities across national centers of excellence in the disease area. In addition to enabling engagement planning with key opinion leaders and hospital leadership at ... read more »

TAGS:                               

Medical Affairs: Find the Missing KOLs

March 20, 2014 · Leave a comment

By Brian Castle

Thought Leader Select is a company dedicated to one purpose:  helping companies in the life sciences to optimize their relationships with key opinion leaders in medicine.

Biopharmaceutical, device, and diagnostics companies work with thought leaders in particular therapeutic areas and diseases as they develop and manufacture new treatment solutions for patients.  It’s well-known that these companies recruit doctors to share their success stories for product marketing purposes, but in the case of product development and refinement, physicians play a critical role, through their collaborations with medical science liaisons and other medical affairs professionals, to push forward medical science in diagnosing and developing the most effective medical and surgical treatments for numerous conditions.

In the last several years, medical science liaisons and their medical affairs colleagues have become the central relationship managers for companies with regard to the leaders in the medical community, the physicians, scientists, and allied health professionals whose work impacts the treatment behavior of thousands of colleagues by virtue of leadership in research, publishing, speaking, development of treatment guidelines and other areas of critical work. With each passing year, it becomes more and more difficult for companies to keep up with the thought leaders in a particular area; this is especially true in very large therapeutic areas like cardiovascular and metabolic conditions and infectious diseases.

How do companies identify ... read more »

TAGS:                                     

MSL Society’s Dyer Publishes New Book to Guide Burgeoning MSLs

February 19, 2014 · Leave a comment

By Brian Castle

For the last couple of years, Thought Leader Select has been a proud partner of the Medical Science Liaison Society, a new non-profit purposed for lifting up the medical science liaison profession worldwide.  It’s a great organization, focused on two areas, networking and education, to provide a platform for MSLs to advance their standing in the life sciences.

As part of his mission to advance the profession from an educational standpoint, the organization’s chairman, Dr. Samuel Dyer, has published his first book.  The Medical Science Liaison Career Guide:  How to Break into Your First Role is the ultimate how-to guide for people looking to join this relatively young profession.  Dyer’s love of the MSL profession, launched in the late Sixties at Upjohn, is evident just in the way he approaches this guide.  This is the type of work that fulfills the mission of his organization—lifting up the profession globally—in a way that has a multiplier effect.

The Medical Science Liaison Career Guide:  How to Break into Your First Role is the gift that has great potential to keep on giving, ... read more »

TAGS:                                 

Thought Leader Select Announces Hiring of Carol Younkin

February 4, 2014 · Leave a comment

February 4, 2014 (CHAPEL HILL, NC) Thought Leader Select, a research and consulting firm serving the life sciences industries of pharmaceuticals, biotechnology, medical devices, and diagnostics, announces the hiring of Carol Younkin to a leadership position in its in-house research group.

Younkin takes on the research manager role at Thought Leader Select after nearly two decades serving pharmaceutical giant Eli Lilly in a variety of capacities, most recently as a medical science liaison supporting the company’s diabetes and growth disorders portfolios. In other roles at Lilly, Younkin managed company relationships with over 100 national and global thought leaders in endocrinology, provided training and consultation to Lilly’s endocrine medical science liaison teams, and developed internal systems for identifying, profiling, and engaging leading medical experts to assist the company in the development of its portfolio of treatments for diabetes.

In her new role at Thought Leader Select, Younkin will lead efforts to identify key opinion leaders and centers of excellence to meet life sciences industry client directives in multiple therapeutic areas and diseases.

Younkin earned a doctorate in health sciences from A.T. Still University and a master’s in health education from Kent State University, where she also earned her bachelor’s degree in nursing.  Her post-graduate studies focused ... read more »

TAGS:                                 

Biopharma Re-engages Thought Leader Select for KOL Work in Bacterial Infections

December 10, 2013 · Leave a comment

December 10, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned a new client engagement to support key opinion leader (KOL) strategies for new treatments in the area of bacterial infections.

The client company, an industry leader in the development of medications to treat various bacterial infections, tabbed North Carolina’s Thought Leader Select to help optimize KOL collaborations in support of its portfolio of medicines for treating anti-biotic-associated infections, including the gram positive bacterial infection, C. difficile.

According to the Centers for Disease Control, C. Difficile is related to the deaths of more than 14,000 Americans each year. Those most at risk are older adults who take antibiotics and receive care at healthcare institutions such as hospitals and clinics.

Thought Leader Select, headquartered in the Research Triangle region of North Carolina, provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies. These custom-tailored services support the necessary and critical industry outreach to and collaboration with leading medical experts, the health care professionals that advance treatment options and promote better public health at regional, national, and global levels.

Earlier this year, Thought Leader Select provided in-house research resulting in foundational data and analytics to facilitate new KOL relationships for the client company in the area of gram ... read more »

TAGS:                                             

US Biopharma Chooses Thought Leader Select for KOL Initiatives in Lupus

December 4, 2013 · Leave a comment

December 4, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, is working with a U.S. biopharmaceutical company on key opinion leader (KOL) initiatives in systemic lupus.

The client company, a leader in developing new medicines for difficult-to-treat auto-immune and inflammatory disorders, chose North Carolina’s Thought Leader Select to assist them with upcoming and ongoing initiatives with national and regional KOLs in the rheumatology community.

The Lupus Foundation of America estimates that there are approximately 1.5 million Americans living with lupus.  About 70 percent of these cases are estimated to be systemic in nature and can affect almost any organ or system in the body, including the skin, joints, lungs, kidneys, heart, nervous system, and brain.   Lupus is a major women’s health issue, with 90 percent of lupus cases affecting women. The Foundation also reports that lupus adversely affects minority women in groups such as African and Native Americans and Latin Americans in rates that are two to three times greater than the rate of incidence among U.S. Caucasian women.

Thought Leader Select, headquartered in the Research Triangle region of North Carolina, provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies. These custom-tailored services support the necessary and critical industry outreach to and collaboration with leading ... read more »

TAGS:                                                         

Happy Thanksgiving from Thought Leader Select

November 27, 2013 · Leave a comment

2013 has been a great year for Thought Leader Select.  Long-time clients have rewarded us with repeat business, and many new clients have entered the fold.  Clients old and new have validated our philosophy and approach to capturing the skills, experiences, and interests of key opinion leaders in medicine, based on an objective, validated methodology that celebrates thought leadership for how it drives industry collaborations for better quality of life for patients and better public health outcomes.

For this validation, and the success that comes with it, we are grateful.

In addition to being grateful to our clients, we are grateful to our business partners, like-minded companies that also love what they do and have helped us expand our capabilities and offerings to our clients.  They are valuable to us because they have created more value for those whom we serve, life sciences companies and the medical community.

And we are certainly appreciative of our employees.  2013 has woven new people into the fabric of Thought Leader Select, and our team is better for it.  When people ask us what makes Thought Leader Select different from our competitors, we believe the answer begins and ends with our people. From our business development consultants with over 50 years of industry experience to the research managers who have worked for decades alongside key opinion leaders ... read more »

TAGS:   

Global Pharma Giant Tabs Thought Leader Select to Optimize KOL Engagements in Diabetes

November 26, 2013 · Leave a comment

November 26, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned new work in support of global key opinion leader (KOL) initiatives in diabetes for a top five global biopharmaceutical company.

The client company, one of the world’s top ten industry leaders in the development of medications across multiple therapeutic areas, tabbed North Carolina’s Thought Leader Select to assist them with upcoming and ongoing initiatives with global KOLs in diabetes, in support of its portfolio of insulin and other medications.

According to International Diabetes Federation estimates, nearly 400 million people worldwide suffer from some form of diabetes.  That number is expected to escalate to nearly 600 million by 2035.

Thought Leader Select, headquartered in the Research Triangle region of North Carolina, provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies. These custom-tailored services support the necessary and critical industry outreach to and collaboration with leading medical experts, the health care professionals that advance treatment options and promote better public health at regional, national, and global levels.

For this global diabetes initiative, Thought Leader Select’s in-house research team will identify nearly 200 global KOLs in diabetes from a range of countries and regions, including the United States and Canada, western Europe, China, Latin America, Asia, and ... read more »

TAGS:                                                           

Older posts »